SURGICAL AND ENDOVASCULAR REVASCULARIZATION OF MYOCARDIUM IN MULTIVESSEL DISEASE
https://doi.org/10.15829/1560-4071-2016-2-90-94
Abstract
The article focuses on the comparative analysis of tactics of the rational complete and incomplete revascularizations in patients with ST elevation myocardial infarction and angina, underwent multivessel stenting and coronary bypass grafting.
Patients with diffuse atherosclerotic lesion of coronary arteries are one of the most strenuous kinds of patients. The demand for revascularization of high in this group and, by the data of several authors, is up to 70% among all surgeries. This origins from the changes in demographics (population ageing) as the manifest of ischemic disease in younger age that further presents with the worse morphological substrate. The problem of optimal tactics choice (coronary bypass, endovascular revascularization, conservative strategy) of diffuse coronary atherosclerosis is still of the main topics in discussion and controversy in science.
About the Authors
I. G. Gordeev
N.I. Pirogov Russian National Research Medical University (RNRMU)
Russian Federation
Moscow
Russian Federation
Moscow
A. Yu. Lebedeva
N.I. Pirogov Russian National Research Medical University (RNRMU)
Russian Federation
Moscow
Russian Federation
Moscow
N. A. Volov
N.I. Pirogov Russian National Research Medical University (RNRMU)
Russian Federation
Moscow
Russian Federation
Moscow
I. S. Grishina
N.I. Pirogov Russian National Research Medical University (RNRMU)
Russian Federation
Moscow
Russian Federation
Moscow
A. S. Semiokhina
N.I. Pirogov Russian National Research Medical University (RNRMU)
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Chen LY, Lennon RJ, Grantham JA, et al. In-hospital and long-term outcomes of multivessel percutaneous coronary revascularization after acute myocardial infarction. Am. J. Cardiol. 2005; 95: 349-54.
2. Tarasov RS, Ganiukov VI, Krotikov JuV, et al. Multiple stents in comparison to the landmark revascularization in patients with STEMI in multivessel coronary lesions. Interventional cardiology 2011/2012; 27/28: 10-7. Russia (Тарасов Р. С., Ганюков В. И., Кротиков Ю. В. и др. Множественное стентирование в сравнении с этапной реваскуляризацией у больных инфарктом миокарда с элевацией сегмента ST при многососудистом поражении коронарного русла. Интервенционная кардиология 2011/2012; 27/28: 10-7).
3. Ioseliany DG, Kostyanov IJu, Vasil’ev PS, et al. The influence of the term of reperfusion myocardium on the nearest and furthest prognosis for the patients with STEMI. Interventional cardiology 2013; 33: 22-33. Russia (Иоселиани Д. Г., Костянов И. Ю., Васильев П. С. и др. Влияние сроков реперфузии миокарда на ближайший и отдаленный прогноз заболевания у больных ОИМ с подъемом сегмента ST (ОИМ-ST). Интервенционная кардиология 2013; 33: 22-33).
4. D'Oliveira R, Gersh BJ, Lima EG, et al. Effect of Complete Revascularization on 10-Year Survival of Patients With Stable Multivessel Coronary Artery Disease: MASS II Trial. Circulation. 2012; 126: 158-63.
5. The BARI 2D Study Group. A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. N. Engl. J. Med. 2009; 360: 2503-15.
6. Frye RL, August Ph, Brooks MM, et al. A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. N. Engl. J. Med. 2009; 360: 2503-15.
7. Puskas JD, Pawale A, Sharma SK Hybrid coronary revascularization. A new treatment paradigm for selected patients with multivessel coronary artery disease. JACC. 2014; 7(10): 1284-6.
8. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. Eur. Heart J. 2005; 26(8): 804-47.
9. Windecker S, Kolh Ph, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur. Heart J. 2014; 35(37): 2541-619.
10. Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary artery bypass grafting for severe coronary artery disease. N. Engl. J. Med. 2009; 360: 961-72.
11. Bonaca MB, Steg PG, Feldman LJ, et al. Antithrombotics in Acute Coronary Syndromes. JACC. 2009; 54(11): 969-84.
12. PRAMI Trial: Complete revascularisation during ST segment elevation myocardial infarction is beneficial. British Cardiovascular Society http://www.bcs.com/pages/news_full.asp?NewsID=19792175 (9 October 2013).
13. Rastan AJ, Walther T, Falk V, et al. Does reasonable incomplete surgical revascularization affect early or long-term survival in patients with multivessel coronary artery disease receiving left internal mammary artery bypass to left anterior descending artery? Circulation 2009; 120: 70-7.
14. Caputo RP, JA, Tremmel JA, et al. Transradial Arterial Access for Coronary and Peripheral Procedures: Executive Summary by the Transradial Committee of the SCAI. Catheterization and Cardiovascular Interventions 2011; 78: 823-39.
15. Khattab AA, Abdel-Wahab M, Rother C, et al. Multivessel stenting during primary percutaneous coronary intervention for acute myocardial infarction. A single-center experience. Clin. Res. Cardiol. 2008; 97: 32-8.
16. Kong JA, Chou ET, Minutello RM, et al. Safety of single versus multi-vessel coronary artery disease: report from the New-York State Angioplasty Registry. Coron. Artery Dis. 2006; 17(1): 71-5.
Review
For citations:
Gordeev I.G., Lebedeva A.Yu., Volov N.A., Grishina I.S., Semiokhina A.S. SURGICAL AND ENDOVASCULAR REVASCULARIZATION OF MYOCARDIUM IN MULTIVESSEL DISEASE. Russian Journal of Cardiology. 2016;(2):90-94. (In Russ.) https://doi.org/10.15829/1560-4071-2016-2-90-94
Views:
2896
Email this article 